+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PTC Therapeutics - logo

PTC Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product candidate is Translarna (ataluren), which is for the treatment of of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is currently in Phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.

Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 220 Pages
  • Global
From
Organ-based/Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030 - Product Thumbnail Image

Organ-based/Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030

  • Report
  • July 2020
  • 283 Pages
  • Global
From
Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027 - Product Thumbnail Image

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

  • Report
  • November 2022
  • 119 Pages
  • Global
From
Global Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region - Product Thumbnail Image

Global Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Huntingtin (Huntington Disease Protein or HTT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Huntingtin (Huntington Disease Protein or HTT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 85 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 366 Pages
  • Global
From
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 64 Pages
  • Global
From
Global Neuromuscular Disease Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Neuromuscular Disease Therapeutics Market 2023-2027

  • Report
  • October 2023
  • 163 Pages
  • Global
From
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2023-2027

  • Report
  • July 2023
  • 154 Pages
  • Global
From
Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 115 Pages
  • Global
From
Global Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032 - Product Thumbnail Image

Global Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032

  • Report
  • April 2024
  • 136 Pages
  • Global
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Global Market Report 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Duchenne Muscular Dystrophy Global Market Report 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Duchenne Muscular Dystrophy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Duchenne Muscular Dystrophy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 170 Pages
  • Global
Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) - Pipeline Insight, 2024 - Product Thumbnail Image

Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Thumbnail Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • December 2023
  • 799 Pages
  • Global
From
Transthyretin Amyloidosis Treatment Global Market Report 2024 - Product Thumbnail Image

Transthyretin Amyloidosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Duchenne Muscular Dystrophy (DMD) Drugs Market Size, Share & Trends Analysis Report By Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy) And Segment Forecasts, 2018 - 2023 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Drugs Market Size, Share & Trends Analysis Report By Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy) And Segment Forecasts, 2018 - 2023

  • Report
  • August 2018
  • 77 Pages
  • Global
From
Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics - Product Thumbnail Image

Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics

  • Report
  • March 2020
  • 357 Pages
  • Global
From
Becker Muscular Dystrophy Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Becker Muscular Dystrophy Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 84 Pages
  • Global
From
Loading Indicator